Sustained delivery of BMP-2 and platelet-rich plasma-released growth factors contributes to osteogenesis of human adipose-derived stem cells

Orthopedics

Volumn 35, Issue 9, 2012, Pages

  Chen, Linwei ^a,b   Lu, Xiaolang ^b   Li, Shi ^b   Sun, Qizhi ^c   Li, Wanli ^a   Song, Dianwen ^d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c Department of Orthopaedics   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; MESSENGER RNA; MICROSPHERE; OSTEOCALCIN; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR AB; TRANSFORMING GROWTH FACTOR BETA1;

ADIPOSE DERIVED STEM CELL; ADULT; ARTICLE; BONE DEVELOPMENT; BONE MATURATION; BONE MINERALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; ENCAPSULATION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; PROTEIN EXPRESSION; SUSTAINED RELEASE PREPARATION; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

ADIPOSE TISSUE; BONE MORPHOGENETIC PROTEIN 2; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OSTEOGENESIS; PLATELET-RICH PLASMA; STEM CELLS; TREATMENT OUTCOME;

EID: 84866291403     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20120822-29     Document Type: Article

References (22)

1. Panetta NJ, Gupta DM, Lee JK, Wan DC, Commons GM, Longaker MT. Human adipose-derived stromal cells respond to and elaborate bone morphogenetic protein-2 during in vitro osteogenic differentiation. Plast Reconstr Surg. 2010; 125(2):483-493.
2. Strem BM, Hicok KC, Zhu M, et al. Multipotential differentiation of adipose tissue-derived stem cells. Keio J Med. 2005; 54(3):132-141. (Pubitemid 41542713)
3. Liu Y, Zhou Y, Feng H, Ma GE, Ni Y. Injectable tissue-engineered bone composed of human adipose-derived stromal cells and platelet-rich plasma. Biomaterials. 2008; 29(23):3338-3345.
4. Park EJ, Kim ES, Weber HP, Wright RF, Mooney DJ. Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2. Int J Oral Maxillofac Implants. 2008; 23(5):818-826.
5. Rao RD, Gourab K, Bagaria VB, Shidham VB, Metkar U, Cooley BC. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein. J Bone Joint Surg Am. 2009; 91(5):1199-1206.
6. Jung RE, Schmoekel HG, Zwahlen R, Kokovic V, Hammerle CH, Weber FE. Platelet-rich plasma and fibrin as delivery systems for recombinant human bone morphogenetic protein-2. Clin Oral Implants Res. 2005; 16(6):676-682. (Pubitemid 43951429)
7. Holland TA, Bodde EW, Cuijpers VM, et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage. 2007; 15(2):187-197. (Pubitemid 46132102)
8. Ahmed TA, Dare EV, Hincke M. Fibrin: a versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev. 2008; 14(2):199-215. (Pubitemid 351839214)
9. Wall ME, Bernacki SH, Loboa EG. Effects of serial passaging on the adipogenic and osteogenic differentiation potential of adipose-derived human mesenchymal stem cells. Tissue Eng. 2007; 13(6):1291-1298. (Pubitemid 46986729)
10. Han J, Meng HX, Tang JM, Li SL, Tang Y, Chen ZB. The effect of different platelet-rich plasma concentrations on proliferation and differentiation of human periodontal ligament cells in vitro. Cell Prolif. 2007; 40(2):241-252. (Pubitemid 46398819)
11. Lei H, Xiao R, Tang XJ, Gui L. Evaluation of the efficacy of platelet-rich plasma in delivering BMSCs into 3D porous scaffolds. J Biomed Mater Res B Appl Biomater. 2009; 91 (2):679-691.
12. Basmanav FB, Kose GT, Hasirci V. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials. 2008; 29(31):4195-4204.
13. Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aaron R, Mathiowitz E. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials. 2008; 29(10):1518-1525.
14. Patel ZS, Young S, Tabata Y, Jansen JA, Wong ME, Mikos AG. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone. 2008; 43(5):931-940.
15. Simmons CA, Alsberg E, Hsiong S, Kim WJ, Mooney DJ. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone. 2004; 35(2):562-569. (Pubitemid 38953205)
16. Holland TA, Tabata Y, Mikos AG. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release. 2005; 101(1-3):111-125. (Pubitemid 39600976)
17. Babbush CA, Kevy SV, Jacobson MS. An in vitro and in vivo evaluation of autologous platelet concentrate in oral reconstruction. Implant Dent. 2003; 12(1):24-34.
18. Levi B, James AW, Wan DC, Glotzbach JP, Commons GW, Longaker MT. Regulation of human adipose-derived stromal cell osteogenic differentiation by insulin-like growth factor-1 and platelet-derived growth factor-alpha. Plast Reconstr Surg. 2010; 126(1):41-52.
19. Levi B, James AW, Xu Y, Commons GW, Longaker MT. Divergent modulation of adipose-derived stromal cell differentiation by TGF-beta1 based on species of derivation. Plast Reconstr Surg. 2010; 126(2):412-425.
20. Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004; 62(4):489-496. (Pubitemid 38451232)
21. Calori GM, Tagliabue L, Gala L, Imporzaro MD, Peretti G, Albisetti W. Application of rh-BMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. Injury. 2008; 39(12):1391-1402.
22. Gigante A, Cappella M, Manzotti S, et al. Osteoinduction properties of different growth factors on cells from non-union patients: in vitro study for clinical application. J Biol Regul Homeost Agents. 2010; 24(1):51-62.